非核苷类逆转录酶抑制剂奈韦拉平和依非韦伦之间的体外抗HIV-1协同作用。 - Suppr

Suppr

超能文献

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

作者信息

Kollmann C, Tremblay C, Giguel F, Chou T C, Hirsch M S

机构信息

Program in Virology, Harvard University, Boston, Mass, USA.

出版信息

Antivir Ther. 2001 Jun;6(2):143-4.

PMID:11491419

Abstract

摘要

相似文献

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

Antivir Ther. 2001 Jun;6(2):143-4.

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.

J Virol. 2001 Jun;75(11):4999-5008. doi: 10.1128/JVI.75.11.4999-5008.2001.

Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

J Med Virol. 2001 Nov;65(3):445-8.

[Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].

Yao Xue Xue Bao. 2004 Aug;39(8):666-72.

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

Antiviral Res. 1998 Jun;38(3):153-79. doi: 10.1016/s0166-3542(98)00025-4.

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

J Infect Dis. 2004 May 1;189(9):1688-95. doi: 10.1086/382960. Epub 2004 Apr 13.

[The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].

Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1719-22.

Efavirenz: resistance and cross-resistance.

Int J Clin Pract Suppl. 1999 Jun;103:21-5.

F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.

Antimicrob Agents Chemother. 2012 Jan;56(1):341-51. doi: 10.1128/AAC.05537-11. Epub 2011 Oct 28.

Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.

Antivir Ther. 2000 Sep;5(3):187-94.

引用本文的文献

Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1.

J Gen Virol. 2017 Apr;98(4):821-834. doi: 10.1099/jgv.0.000728. Epub 2017 May 5.

The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates.

J Virol Methods. 2010 Oct;169(1):39-46. doi: 10.1016/j.jviromet.2010.06.012. Epub 2010 Jun 25.

Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.

Antimicrob Agents Chemother. 2002 Jun;46(6):1640-6. doi: 10.1128/AAC.46.6.1640-1646.2002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.

作者信息

Kollmann C, Tremblay C, Giguel F, Chou T C, Hirsch M S

机构信息

Program in Virology, Harvard University, Boston, Mass, USA.

出版信息

Antivir Ther. 2001 Jun;6(2):143-4.

PMID:11491419

Abstract

摘要